Risk factors for intestinal failure in infants with necrotizing enterocolitis: a Glaser Pediatric Research Network study.
Debora Duro, Leslie A Kalish, Patrick Johnston...
https://pubmed.ncbi.nlm.nih.gov/20447649/Actively Recruiting
Led by IWK Health Centre · Updated on 2026-09-29
4333
Participants Needed
40
Research Sites
N/A
Total Duration
This research aims to compare two standard care approaches in very premature infants born before 30 weeks to see if withholding enteral feeds around the time of blood transfusion reduces the risk of Necrotizing Enterocolitis NEC, a serious intestinal disease. NEC can severely damage the bowel and has a high risk of death or long-term health problems. The study involves infants from neonatal intensive care units in Canada and the UK and evaluates if withholding or continuing feeds during transfusion affects outcomes. The study randomly assigns infants to one of two groups one where all enteral feeds are stopped for 4 hours before, during, and after packed red cell transfusion and another where feeding continues as usual throughout the transfusion period. Infants will remain on their assigned feeding strategy until reaching 34 weeks and 6 days gestational age. During feed withholding, hydration and blood sugar are maintained by parenteral nutrition or intravenous glucose according to local practice. Participants will be monitored from randomization until 40 weeks postmenstrual age for the development and severity of NEC, death, infections, nutritional support duration, growth, and other health outcomes. Researchers will track feeding practices, transfusions, and clinical events, with long-term follow-up until discharge from the hospital. The study intends to identify which feeding approach during transfusion might better prevent NEC in these vulnerable infants.
CONDITIONS
WithHolding Enteral Feeds Around Blood Transfusion (International)
C
Cari-Lee Carnell
T
Tara Hatfield
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
IWK Health Centre
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 screening visit
Duration - Until 34 weeks and 6 days gestational age
Participants are randomly assigned to one of two feeding approaches during blood transfusions: feeds are either withheld for a set period around transfusion or continued as usual until reaching 34 weeks and 6 days gestational age.
Regular monitoring visits during the treatment period
Duration - Up to 40 weeks postmenstrual age
Participants are monitored for health outcomes including Necrotizing Enterocolitis, infections, growth, and other conditions until 40 weeks postmenstrual age and discharge from hospital.
Regular assessments until hospital discharge
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
OTHER
Number of Arms
2
Have more questions? Get in touch with our team for quick support
Debora Duro, Leslie A Kalish, Patrick Johnston...
https://pubmed.ncbi.nlm.nih.gov/20447649/Clare M Rees, Agostino Pierro, Simon Eaton
https://pubmed.ncbi.nlm.nih.gov/16984980/R A Seges, A Kenny, G W Bird...
https://pubmed.ncbi.nlm.nih.gov/6279816/Pradeep Mally, Sergio G Golombek, Ravi Mishra...
https://pubmed.ncbi.nlm.nih.gov/17009195/Cheryl Battersby, Nick Longford, Sundhiya Mandalia...
https://pubmed.ncbi.nlm.nih.gov/28404014/Suzan Sahin, H Gozde Kanmaz Kutman, Ozlem Bozkurt...
https://pubmed.ncbi.nlm.nih.gov/30890001/Haresh Kirpalani, Robin K Whyte, Chad Andersen...
https://pubmed.ncbi.nlm.nih.gov/16939737/Amy K Keir, Junmin Yang, Adele Harrison...
https://pubmed.ncbi.nlm.nih.gov/25652740/Lelia Duley, Seilin Uhm, Sandy Oliver...
https://pubmed.ncbi.nlm.nih.gov/24931684/J Neu
https://pubmed.ncbi.nlm.nih.gov/8614608/IWK Health Centre
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborating Sponsor